Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Sure, it’s called shorting a stock.
NP will get his ass handed to him by the SEC if he tries that on Nasdaq.
Fiduciary responsibility, respectable funds don’t invest in OTC. When they get to Nasdaq that will change quickly and shares will dry up fast.
Just a repeat of facts already known. Nothing new here. Leronlimab to be the new SOC
What “scenes” and why hide it?
How fast can NP sell a ton of leronlimab to Brazil? They are hurting. If he’s truly a car salesman then it should be no problem, lol.
Skip the Feds, sell the drugs.
Not yet.... there’s green oil coming. It’s all the rage.
That is very true... but he needs help and he needs to listen to that help to get up to the big boys table.
Agreed. BP just sits there and smiles... he knows. I cringe when NP talks but he’s brought it this far. I say cash him out and hire a CEO that can finish the job.
Can’t the board remove him once they have a good CEO lined up?
They will fine him directly just like Elon Musk. Then eventually they will force him out. Just watch.
Inexperience... he has no background in this market... at all.
Good summary, NP is getting after it, love it.
The fact his family biz is tied into this is the sad part. 43% of Rottman ownership didn’t want to sell to Vystar... now we know why.
Can big Steve control his boy? At this point I’m not sure he even knows what Greg is doing.
Even worse... kinda figured that was a incorrect figure
Yes, NP would need to get his PRs and CCs carefully.
I think that BigPharma/FDA knows this and will just wait out CytoDyn until they are forced to dilute so the short positions can cover.
Then they’ll MAYBE let CytoDyn play ball.
Chas education resume is impressive. His days in the “mining biz” shouldn’t muddy up the diamond biz though... old tricks won’t work here...
Need an honest attempt to commercialize this diamond making machine Snaper said was done
Gilead spends $2mil a year making sure Congress doesn’t allow competition.
I’m betting they’ll work off anecdotal evidence. Down there in LatAm if a lot of people die unjustly the government gets overthrown.
Here in USA we just lower flags to half mast and attack other nations.
Hence there’s more accountability and more of a sense of urgency.
Greg says no reason to sell through distributors. Even through they have distributors.
There’s a reason why they don’t want to have shareholder conf calls... they’d get ripped pretty bad I’d think.
Nope, they don’t.
That would be great, but evidence has proven otherwise previously.
I wish the company would not be dormant and actually do some business when it’s as ripe as it is.
Yep, they are way behind and lost. Not shocked.
Shorting a biologics stocks in Covid era that has many catalysts on deck with an aggressive CEO is beyond stupid.
But based on AF and Co tweets I can see it fits. They can argue fraud but that doesn’t matter... NP holds the cards right now.
He could do better a job of selling shares if he could muster a pic of 50 RXAIR units. He can’t even pump well... sad.
I would take .04 easy... sold all
Lots over that at a loss. That money can be made back elsewhere... not here. Management is way too dumb to capitalize on current IP assets.
Would love to be proven wrong but I’m not going to wait.
In all seriousness the only thing leronlimab is missing is a sexy marketing jingle...
Truth, price might be higher though.
Only in the OTC. Where there are no laws, no sheriff.
If Chas is a BS then why call? I just keep selling my shares slowly. Sometimes for losses, sometimes for gains.
I invested in Snaper in 2012, not Chas.
I wouldn’t be surprised if it’s still ignored even then.
Lol... fire him on the spot then. Fauci knows about leronlimab.
Yes, that’s been the boards point since March. It’s a trillion dollar waiting game. All of this BS drama in the news is negated once leronlimab is available to the masses.
Old news to us but still new news to the medical community since the media refuses to cover it.
It’s a shame it’s getting shaded like it is, people are dying unnecessarily.
NP is not good in interviews. The people interviewing him try to keep him on point but it doesn’t always work.
Wait what? Someone dropped $74k on this POS?
Shorts are gone likely because there’s a hard bottom established by large investor looking for a better price.
Agreed, I hope.
VYST/UVFT etc has created a good deal of seriously pissed off shareholders that only see a Greg pattern of deceitful behavior. This will long haunt Vystar and there are many who are warning other investors to stay away.
Steve Rottman needs to address this personally, otherwise his equity (Share price) will be forever shaded and hampered.
It’s a shame really, but I don’t see it getting better until they hire a decent PR firm and kill the twitter account. Shareholders want Conf calls with Steve.